Income Statement (TTM)
NuGen Medical Devices Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Change (%) | 33.32 | 103.91 | 5.39 | 1.58 | 37.67 | -3.90 | -12.49 | -4.39 | -28.38 | -33.18 | 153.31 | 79.42 | 6.95 | -2.15 | 119.95 | 32.39 | 6.88 | 0.67 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Change (%) | 40.29 | 120.53 | 22.13 | -6.87 | 38.19 | 26.72 | -42.39 | 16.07 | -28.87 | -75.95 | 740.46 | 117.76 | 8.32 | -2.26 | 129.18 | 20.73 | 6.40 | 0.58 | |
| % of Revenue | 27.30 | 28.72 | 31.06 | 36.00 | 33.00 | 33.12 | 43.68 | 28.76 | 34.91 | 34.67 | 12.48 | 41.41 | 50.26 | 50.91 | 50.85 | 52.99 | 48.32 | 48.10 | 48.06 |
| Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Change (%) | 30.70 | 97.21 | -2.15 | 6.34 | 37.42 | -19.07 | 10.70 | -12.65 | -28.12 | -10.48 | 69.58 | 52.32 | 5.56 | -2.04 | 110.41 | 45.54 | 7.33 | 0.75 | |
| % of Revenue | 72.70 | 71.28 | 68.94 | 64.00 | 67.00 | 66.88 | 56.32 | 71.24 | 65.09 | 65.33 | 87.52 | 58.59 | 49.74 | 49.09 | 49.15 | 47.01 | 51.68 | 51.90 | 51.94 |
| SG&A | 2 | 3 | 3 | 4 | 5 | 6 | 6 | 5 | 4 | 4 | 5 | 7 | 8 | 7 | 6 | 6 | 5 | 4 | 5 |
| Change (%) | 30.55 | 9.13 | 32.04 | 23.78 | 10.32 | 5.17 | -15.56 | -17.67 | 2.19 | 20.04 | 25.49 | 15.22 | -2.31 | -18.94 | 4.15 | -18.87 | -11.74 | 7.21 | |
| % of Revenue | 4,773.83 | 4,674.77 | 2,501.82 | 3,134.53 | 3,819.44 | 3,060.67 | 3,349.69 | 3,232.34 | 2,783.45 | 3,971.45 | 7,134.47 | 3,534.48 | 2,269.76 | 2,073.43 | 1,717.71 | 813.38 | 498.44 | 411.59 | 438.33 |
| R&D | |||||||||||||||||||
| Change (%) | |||||||||||||||||||
| % of Revenue | |||||||||||||||||||
| OpEx | 3 | 3 | 4 | 4 | 6 | 6 | 7 | 6 | 5 | 5 | 6 | 7 | 8 | 8 | 7 | 7 | 6 | 6 | 6 |
| Change (%) | 26.35 | 17.02 | 14.06 | 33.33 | 9.45 | 4.41 | -7.94 | -20.71 | 5.22 | 14.00 | 24.39 | 13.53 | -2.01 | -17.23 | 6.65 | -14.92 | -9.32 | 5.85 | |
| % of Revenue | 5,575.96 | 5,284.35 | 3,032.58 | 3,282.17 | 4,307.91 | 3,424.63 | 3,720.94 | 3,914.81 | 3,246.56 | 4,769.84 | 8,137.31 | 3,995.90 | 2,528.48 | 2,316.80 | 1,959.84 | 950.30 | 610.70 | 518.16 | 544.82 |
| Operating Income | -3 | -3 | -4 | -4 | -6 | -6 | -7 | -6 | -5 | -5 | -6 | -7 | -8 | -8 | -6 | -6 | -5 | -5 | -5 |
| Change (%) | 26.22 | 15.34 | 14.36 | 34.33 | 8.77 | 4.66 | -7.81 | -21.14 | 6.29 | 15.01 | 22.79 | 11.84 | -2.38 | -17.91 | 0.56 | -20.48 | -12.49 | 7.09 | |
| % of Revenue | -5,475.96 | -5,184.35 | -2,932.58 | -3,182.17 | -4,207.91 | -3,324.63 | -3,620.94 | -3,814.81 | -3,146.56 | -4,669.84 | -8,037.31 | -3,895.90 | -2,428.48 | -2,216.80 | -1,859.84 | -850.30 | -510.70 | -418.16 | -444.82 |
| Interest Expense | -0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | -2 |
| Change (%) | 45.20 | 21.99 | 1.57 | 61.40 | 2.52 | -6.67 | -0.34 | -12.51 | 7.97 | 6.56 | 5.75 | 0.46 | -0.36 | 0.91 | 1.85 | 31.79 | 21.83 | 20.75 | |
| % of Revenue | -882.90 | -961.60 | -575.29 | -554.42 | -880.87 | -655.94 | -637.04 | -725.49 | -663.89 | -1,000.88 | -1,596.07 | -666.28 | -373.05 | -347.58 | -358.47 | -165.98 | -165.23 | -188.35 | -225.93 |
| Net Income | -4 | -5 | -5 | -5 | -7 | -7 | -8 | -7 | -6 | -6 | -7 | -9 | -9 | -9 | -8 | -8 | -5 | -2 | -3 |
| Change (%) | 27.95 | 6.37 | -2.34 | 45.69 | 3.79 | 5.61 | -4.87 | -24.74 | 11.08 | 15.81 | 18.93 | 9.70 | -3.04 | -15.90 | 8.86 | -37.12 | -64.91 | 75.05 | |
| % of Revenue | -7,760.66 | -7,447.94 | -3,885.06 | -3,600.11 | -5,163.23 | -3,892.45 | -4,278.00 | -4,650.72 | -3,661.07 | -5,677.96 | -9,840.56 | -4,620.29 | -2,825.02 | -2,561.28 | -2,201.33 | -1,089.45 | -517.47 | -169.90 | -295.45 |
Source: Capital IQ
